title: Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination.
abstract: Wnt/beta-catenin signalling pathway is integrally associated with human tumour development and progression. Aberrant beta-catenin intracellular distribution has been found in gastric cancer, but the pattern of Wnt expression in stepwise gastrocarcinogenesis and its potential influence in beta-catenin distribution are still lesser known. By the methods of frozen tissue array-based immunohistochemistry, Western blot analysis and RT-PCR, a paralleled study was conducted to check Wnt2 expression and beta-catenin intracellular distribution in two major subtypes of gastric cancers (intestinal gastric cancer, i-GC and diffuse gastric cancer, d-GC) and their premalignant (intestinal metaplasia, IM and chronic gastritis, CG) and noncancerous counterparts. According to the results obtained and the clinical data collected, correlation of Wnt2 expression with beta-catenin translocalisation and their links with tumour dissemination were elucidated. The results demonstrated (1) that Wnt2 expression and cytoplasmic/nuclear beta-catenin accumulations appeared in most gastric cancers irrespective to their morphological phenotypes, (2) that over-expressed Wnt and nuclear translocalisation of beta-catenin were found in 68 and 58% of i-GCs and in 47 and 47% of d-GCs in a closely related pattern (P<0.01) and (3) that co-existence of Wnt2 up-regulation/beta-catenin nuclear translocalisation were positively associated with lymph node metastasis (P<0.05) as well as T-stage. These data indicate that Wnt/beta-catenin signalling pathway is activated in most of gastric cancers, which may play pivotal roles either in gastric cancer formation or in tumour invasion and dissemination.
authors.affiliation: Cancer Institute, College of Basic Medical Sciences, Dalian Medical University, Dalian 116027, People's Republic of China.
authors.forename: Xiao-Xin
authors.initials: XX
authors.lastname: Cheng
authors.forename: Zi-Chuang
authors.initials: ZC
authors.lastname: Wang
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Chen
authors.forename: Yuan
authors.initials: Y
authors.lastname: Sun
authors.forename: Qing-You
authors.initials: QY
authors.lastname: Kong
authors.forename: Jia
authors.initials: J
authors.lastname: Liu
authors.forename: Hong
authors.initials: H
authors.lastname: Li
mesh_terms: D015153:Blotting, Western; D002467:Cell Nucleus / Q000737:chemistry; D002471:Cell Transformation, Neoplastic; D002681:China; D003593:Cytoplasm; D003598:Cytoskeletal Proteins / Q000096:biosynthesis* / Q000493:pharmacokinetics*; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D011230:Precancerous Conditions; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis* / Q000493:pharmacokinetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D013274:Stomach Neoplasms / Q000235:genetics* / Q000503:physiopathology*; D015534:Trans-Activators / Q000096:biosynthesis* / Q000493:pharmacokinetics*; D015854:Up-Regulation; D051154:Wnt2 Protein; D051176:beta Catenin
chemical_list: C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D051154:Wnt2 Protein; D051176:beta Catenin